tirzepatide weight loss dothan Where to Get for in Fayetteville, NC Tirzepatide Injections in Orlando, FL

Tirzepatide, marketed as Mounjaro for type 2 diabetes and Zepbound for weight management, is a dual GIP/GLP-1 receptor agonist that patients often wonder about regarding onset of action

In one real-world study, patients on tirzepatide lost 15.3% of their body weight at 12 months, compared to 8.3% for those on semaglutide

All of these benefits translate directly to improved erectile function

The summary below pulls the headline numbers from each pivotal study

Our experienced medical team at the Center for SmartLipo recommends that patients verify their coverage directly with their insurance provider to determine eligibility, potential out-of-pocket costs, and whether any restrictions or special requirements apply

Despite producing more weight loss, tirzepatide had lower rates of treatment discontinuation due to gastrointestinal adverse events (2.7% vs 5.6% for semaglutide)